{"id":208,"date":"2014-01-10T14:24:53","date_gmt":"2014-01-10T14:24:53","guid":{"rendered":"http:\/\/www.farmacovigilanciacanarias.org\/noticias\/?p=208"},"modified":"2014-01-10T14:24:53","modified_gmt":"2014-01-10T14:24:53","slug":"nota-informativa-muh-fv-12014","status":"publish","type":"post","link":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/2014\/01\/10\/nota-informativa-muh-fv-12014\/","title":{"rendered":"Nota Informativa MUH (FV), 1\/2014"},"content":{"rendered":"<p><a href=\"http:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/seguridad\/2014\/NI-MUH_FV_01-2014-ranelato-estroncio.htm\">Ranelato de estroncio (\u25bcOsseor\u00ae, \u25bcProtelos\u00ae): la revisi\u00f3n europea concluye que el balance beneficio-riesgo es desfavorable<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ranelato de estroncio (\u25bcOsseor\u00ae, \u25bcProtelos\u00ae): la revisi\u00f3n europea concluye que el balance beneficio-riesgo es desfavorable<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-208","post","type-post","status-publish","format-standard","hentry","category-seguridad"],"_links":{"self":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/comments?post=208"}],"version-history":[{"count":1,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/208\/revisions"}],"predecessor-version":[{"id":209,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/208\/revisions\/209"}],"wp:attachment":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/media?parent=208"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/categories?post=208"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/tags?post=208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}